As the landscape of e-cigarette use continues to evolve in the US, research has been mounting on the potential health harms. Previous studies have shown that e-cigarette use contributes to heart and lung disease. Now, a recent case control study conducted in Ohio shows a potential link between dual use – smoking both cigarettes and vaping – and an increased risk of lung cancer. The bottom line: those who smoke and vape have increased lung cancer risk.

These new tobacco products are becoming popular, and it is important to understand the health risks of nicotine pouches. In January, the US Food and Drug Administration (FDA) authorized the marketing and sale of 20 different Zyn nicotine pouch products. This does not mean these products are approved by the FDA as a safe drug. It simply means they’ve allowed the company to sell these tobacco products in the US.

A recent study published in the peer-reviewed Journal of the American Medical Association (JAMA) shows promising results on use of the varenicline (generic Chantix) in adolescents and young adults who vape nicotine. When compared to placebo or behavioral counseling alone, participants taking varenicline had more than three times higher abstinence rates. Overall, varenicline was well tolerated, with only two participants leaving the study due to adverse effects.